144 related articles for article (PubMed ID: 26636928)
41. Tubular and glomerular proteinuria in HIV-infected adults with estimated glomerular filtration rate ≥ 60 ml/min per 1.73 m2.
Reynes J; Cournil A; Peyriere H; Psomas C; Guiller E; Chatron M; Cristol JP; Badiou S
AIDS; 2013 May; 27(8):1295-302. PubMed ID: 23925378
[TBL] [Abstract][Full Text] [Related]
42. Long-Term Follow-Up of Proteinuria and Estimated Glomerular Filtration Rate in HIV-Infected Patients with Tubular Proteinuria.
Peyriere H; Cournil A; Casanova ML; Badiou S; Cristol JP; Reynes J
PLoS One; 2015; 10(11):e0142491. PubMed ID: 26571117
[TBL] [Abstract][Full Text] [Related]
43. Renal function of MDR-TB patients treated with kanamycin regimens or concomitantly with antiretroviral agents.
Sagwa EL; Ruswa N; Mavhunga F; Rennie T; Mengistu A; Mekonen TT; Leufkens HGM; Mantel-Teeuwisse AK
Int J Tuberc Lung Dis; 2017 Dec; 21(12):1245-1250. PubMed ID: 29297444
[TBL] [Abstract][Full Text] [Related]
44. Population Pharmacokinetic Modeling of Tenofovir in the Genital Tract of Male HIV-Infected Patients.
Valade E; Bouazza N; Lui G; Illamola SM; Benaboud S; Treluyer JM; Cobat A; Foissac F; De Sousa Mendes M; Chenevier-Gobeaux C; Suzan-Monti M; Rouzioux C; Assoumou L; Viard JP; Urien S; Ghosn J; Hirt D
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27956420
[TBL] [Abstract][Full Text] [Related]
45. Minor changes in calculated creatinine clearance and anion-gap are associated with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy.
Winston A; Amin J; Mallon P; Marriott D; Carr A; Cooper DA; Emery S
HIV Med; 2006 Mar; 7(2):105-11. PubMed ID: 16420255
[TBL] [Abstract][Full Text] [Related]
46. Optimizing antiretroviral regimens in chronic kidney disease.
Hamzah L; Jones R; Post FA
Curr Opin Infect Dis; 2019 Feb; 32(1):1-7. PubMed ID: 30461453
[TBL] [Abstract][Full Text] [Related]
47. Renal function in antiretroviral-experienced patients treated with tenofovir disoproxil fumarate associated with atazanavir/ritonavir.
Gérard L; Chazallon C; Taburet AM; Girard PM; Aboulker JP; Piketty C
Antivir Ther; 2007; 12(1):31-9. PubMed ID: 17503745
[TBL] [Abstract][Full Text] [Related]
48. Resistance profiles of emtricitabine and lamivudine in tenofovir-containing regimens.
Marcelin AG; Charpentier C; Wirden M; Landman R; Valantin MA; Simon A; Katlama C; Yeni P; Descamps D; Aubron-Olivier C; Calvez V
J Antimicrob Chemother; 2012 Jun; 67(6):1475-8. PubMed ID: 22371439
[TBL] [Abstract][Full Text] [Related]
49. Changes in the renal function after tenofovir-containing antiretroviral therapy initiation in a Senegalese cohort (ANRS 1215).
De Beaudrap P; Diallo MB; Landman R; Guèye NF; Ndiaye I; Diouf A; Kane CT; Etard JF; Girard PM; Sow PS; Delaporte E;
AIDS Res Hum Retroviruses; 2010 Nov; 26(11):1221-7. PubMed ID: 20854202
[TBL] [Abstract][Full Text] [Related]
50. Steady-state amprenavir and tenofovir pharmacokinetics after coadministration of unboosted or ritonavir-boosted fosamprenavir with tenofovir disoproxil fumarate in healthy volunteers.
Luber AD; Condoluci DV; Slowinski PD; Andrews M; Olson K; Peloquin CA; Pappa KA; Pakes GE;
HIV Med; 2010 Mar; 11(3):193-9. PubMed ID: 19863619
[TBL] [Abstract][Full Text] [Related]
51. Evolution of glomerular filtration rate in HIV-infected, HIV-HBV-coinfected and HBV-infected patients receiving tenofovir disoproxil fumarate.
Pradat P; Le Pogam MA; Okon JB; Trolliet P; Miailhes P; Brochier C; Maynard M; Bailly F; Zoulim F; Cotte L
J Viral Hepat; 2013 Sep; 20(9):650-7. PubMed ID: 23910650
[TBL] [Abstract][Full Text] [Related]
52. ABCC2*1C and plasma tenofovir concentration are correlated to decreased glomerular filtration rate in patients receiving a tenofovir-containing antiretroviral regimen.
Manosuthi W; Sukasem C; Thongyen S; Nilkamhang S; Sungkanuparph S
J Antimicrob Chemother; 2014 Aug; 69(8):2195-201. PubMed ID: 24788661
[TBL] [Abstract][Full Text] [Related]
53. The impact of tenofovir disoproxil fumarate on kidney function: four-year data from the HIV-infected outpatient cohort.
Monteiro N; Branco M; Peres S; Borges F; Mansinho K
J Int AIDS Soc; 2014; 17(4 Suppl 3):19565. PubMed ID: 25394072
[TBL] [Abstract][Full Text] [Related]
54. Clinic-Based Evaluation of a Point-of-Care Creatinine Assay to Screen for Renal Impairment Among HIV-Positive Patients Receiving Tenofovir Disoproxil Fumarate.
Dorward J; Yende-Zuma N; Samsunder N; Karim QA; Drain PK; Garrett N
J Acquir Immune Defic Syndr; 2018 Apr; 77(4):e36-e39. PubMed ID: 29271830
[No Abstract] [Full Text] [Related]
55. Brief Report: Subclinical Kidney Dysfunction in HIV-Infected Children: A Cross-Sectional Study.
Bk K; Tiwari S; Chhapola V; Debnath E; Seth A; Jain A
J Acquir Immune Defic Syndr; 2020 Dec; 85(4):470-474. PubMed ID: 33136747
[TBL] [Abstract][Full Text] [Related]
56. Impact of Sex on the Pharmacokinetics and Pharmacodynamics of 1% Tenofovir Gel.
Herold BC; Chen BA; Salata RA; Marzinke MA; Kelly CW; Dezzutti CS; McGowan I; Galaska B; Levy L; Piper JM; Hillier S; Hendrix CW
Clin Infect Dis; 2016 Feb; 62(3):375-382. PubMed ID: 26508513
[TBL] [Abstract][Full Text] [Related]
57. Polymorphisms of tenofovir disoproxil fumarate transporters and risk of kidney tubular dysfunction in HIV-positive patients: genetics of tenofovir transporters.
Danjuma MI; Egan D; Abubeker IY; Post F; Khoo S
Int J STD AIDS; 2018 Aug; ():956462418786562. PubMed ID: 30071797
[TBL] [Abstract][Full Text] [Related]
58. Plasma tenofovir trough concentrations are associated with renal dysfunction in Japanese patients with HIV infection: a retrospective cohort study.
Kunimoto Y; Ikeda H; Fujii S; Kitagawa M; Yamazaki K; Nakata H; Noda N; Ishida T; Miyamoto A
J Pharm Health Care Sci; 2016; 2():22. PubMed ID: 27688900
[TBL] [Abstract][Full Text] [Related]
59. Correlation Between Tenofovir Drug Levels and the Renal Biomarkers RBP-4 and ß2M in the ION-4 Study Cohort.
Chan A; Park L; Collins LF; Cooper C; Saag M; Dieterich D; Sulkowski M; Naggie S
Open Forum Infect Dis; 2019 Jan; 6(1):ofy273. PubMed ID: 30697570
[TBL] [Abstract][Full Text] [Related]
60. Associations between plasma tenofovir concentration and renal function markers in HIV-infected women.
Mulubwa M; Rheeders M; Fourie C; Viljoen M
South Afr J HIV Med; 2016; 17(1):458. PubMed ID: 29568614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
